Cullinan Therapeutics (CGEM) Shares Issued (2020 - 2025)

Cullinan Therapeutics' Shares Issued history runs 6 years deep, the most recent figure standing at $9.4 million for Q4 2025.

• On a quarterly basis, Shares Issued fell 18.78% year-over-year to $9.4 million in Q4 2025; TTM through Dec 2025 was $9.4 million, a 18.78% decrease from a year earlier, with the FY2025 full-year figure at $9.4 million, down 18.78% from the prior year.
• Shares Issued retreated to $9.4 million in Q4 2025 per CGEM's latest filing, from $11.6 million in the prior quarter.
• Across five years, Shares Issued topped out at $11.6 million in Q4 2024 and bottomed at $1.8 million in Q1 2021.
• The 5-year median for Shares Issued is $9.3 million (2021), against an average of $7.3 million.
• Across the five-year window, Shares Issued surged 101.15% in 2021 and slipped 18.78% in 2025, its largest moves.
• Year by year, Shares Issued stood at $9.3 million in 2021, then gained by 0.81% to $9.3 million in 2022, then gained by 12.91% to $10.5 million in 2023, then climbed by 10.38% to $11.6 million in 2024, then declined by 18.78% to $9.4 million in 2025.
• Per Business Quant, the three latest CGEM Shares Issued figures stand at $9.4 million (Q4 2025), $11.6 million (Q4 2024), and $10.5 million (Q4 2023).